Home » Keywords » adhansia-xr

Items Tagged with 'adhansia-xr'

ARTICLES

In Brief: A 16-Hour Ritalin

October 3, 2019

Chris Aiken, MD

Adhansia XR is a new extended-release methylphenidate. Its distinguishing feature is its 16-hour duration.

FDA Approves Adhansia XR

June 11, 2019

Talia Puzantian, PharmD, BCPP and Joshua Feder, MD

Talia Puzantian, PharmD, BCPP Joshua Feder, MD Drs. Puzantian and Feder have disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In this article we discuss a newly FDA-approved formulation for ADHD. Adhansia XR, is a new formulation of extended-release methylphenidate approved by the FDA for the treatment of ADHD in patients 6 years and older.

Try The New AskCarlat AI

Ask any clinical question—our AI responds using only the peer-reviewed, editorially vetted content from Carlat Publishing.

Complementary and Alternative Medicine in Psychiatry: A Fact Book (2026) -
Fact sheets for 67 treatments that fall outside conventional psychopharmacology.
READ MORE

General Psychiatry
KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything
Read More

Psychology and Social Work
Treating Couples: Integrative Behavioral Couple Therapy — Balancing Acceptance and Change Andrew Christensen, PhD
Dr. Andrew Christensen, distinguished research professor of psychology at UCLA and co-developer of Integrative Behavioral Couple Therapy (IBCT), explains how IBCT balances...
Listen now

Join Our Writing Team
July 18, 2024
Insights About a Rare Transmissible Form of Alzheimer's Disease
February 9, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners
May 24, 2024

Join Our Writing Team
July 18, 2024
Insights About a Rare Transmissible Form of Alzheimer's Disease
February 9, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners
May 24, 2024

Join Our Writing Team
July 18, 2024
Insights About a Rare Transmissible Form of Alzheimer's Disease
February 9, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners
May 24, 2024

Items Tagged with 'adhansia-xr'

ARTICLES

In Brief: A 16-Hour Ritalin

FDA Approves Adhansia XR

Complementary and Alternative Medicine in Psychiatry: A Fact Book (2026) -

KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

Treating Couples: Integrative Behavioral Couple Therapy — Balancing Acceptance and Change Andrew Christensen, PhD

Join Our Writing Team

Insights About a Rare Transmissible Form of Alzheimer's Disease

How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

Join Our Writing Team

Insights About a Rare Transmissible Form of Alzheimer's Disease

How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

Join Our Writing Team

Insights About a Rare Transmissible Form of Alzheimer's Disease

How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

About

Shop Online

Newsletters

Contact

Follow Us